It also deteriorates the already impaired glucose homeostasis in patients with DM and in patients with other comorbidities such as obesity, insulin resistance (IR), hyperinsulinemia and hypertension in whom alterations in insulin secretion are already present and contribute to hyperglycemia [3]. The gene discussed is INS; the disease is Hyperglycemia.